Atrandi Biosciences
Atrandi Biosciences develops partitioning technologies and high-throughput screening platforms for advanced single-cell analysis. The company provides semi-permeable capsules and droplet microfluidics systems that enable researchers to perform multi-step, multi-omic workflows, such as joint RNA and DNA co-sequencing and microbial genomics. Its products serve laboratory researchers in fields like protein engineering, functional assays, and microbiome characterization.
Visit websiteVilnius, Lithuania
Healthtech
Biotechnology
Life Sciences
Genomics
Funding summary
- Total raised
- €24.0M
- Funding rounds
- 1
Investors in Atrandi Biosciences
Investors on record for Atrandi Biosciences. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Atrandi Biosciences?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors